Explaining Nasopharyngeal Cancer Survival Through Machine Learning with LIME and SHAP

Date:

In a recent study, five different machine learning algorithms were leveraged to create a single distinct algorithm known as a stacked algorithm for the prognostication of overall survival outcomes in nasopharyngeal cancer patients. The performance of this algorithm was compared to another state-of-the-art algorithm called extreme gradient boosting (XGBoost). To make the predictions explainable and interpretable, the Local Interpretable Model Agnostic Explanations (LIME) and Shapley Additive exPlanations (SHAP) techniques were used. The resulting model may aid in personalized chance of survival stratification for patients, allowing for tailored treatment intensity. Data from the National Cancer Institute database through the Surveillance, Epidemiology, and End Results (SEER) Program of the National Institutes of Health were used.

The study’s lead author is Alabi Alabir, a Ph.D. student in the Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

The research was conducted independently and did not involve any outside companies.

See also  Revolutionizing Link Building: The Future of AI in SEO

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.